W. Verbeek

发表

DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.

S. Koschmieder, W. Berdel, H. Serve, 2007, Cancer research.

Continuous Complete Hematological and Cytogenetic Remission with Molecular Minimal Residual Disease 9 Years after Discontinuation of Interferon-α in a Patient with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

C. Scheibenbogen, A. Hochhaus, U. Graeven, 2006, Acta Haematologica.

C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters.

A. Chumakov, H. Koeffler, A. Friedman, 1999, Blood.

Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations

W. Hiddemann, C. Fonatsch, B. Wörmann, 1995 .

Identification of Transcriptional Activation and Repression Domains in Human CCAAT/Enhancer-binding Protein ε*

A. Chumakov, E. Williamson, H. Koeffler, 1998, The Journal of Biological Chemistry.

Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils.

H. Koeffler, D. Park, Dorothy J. Park, 1999, Blood.

Myeloid Transcription Factor C/EBPɛ Is Involved in the Positive Regulation of Lactoferrin Gene Expression in Neutrophils

H. Koeffler, Dorothy J. Park, P. T. Vuong, 1999 .

Measurement of thrombopoietic levels: clinical and biological relationships

G. Brittinger, F. Griesinger, W. Verbeek, 2000, Current opinion in hematology.

Regulation of platelet production: biological aspects

G. Brittinger, F. Griesinger, W. Verbeek, 2022 .

Is Kaposi's sarcoma--associated herpesvirus ubiquitous in urogenital and prostate tissues?

H. Koeffler, D. Park, J. Takahara, 1997, Blood.

Vitamin D receptor: no evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism.

H. Koeffler, A. Gombart, M. Campbell, 1997, Biochemical and biophysical research communications.

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

N. Schmitz, M. Stauch, Y. Ko, 2020, Leukemia.

Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi's sarcoma and their clinical follow-up.

H. Koeffler, J. Said, W. Verbeek, 1998, American journal of clinical pathology.

Is Kaposi's Sarcoma–Associated Herpesvirus Ubiquitous in Urogenital and Prostate Tissues?

H. Koeffler, J. Takahara, Dorothy J. Park, 1997 .

S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes

W. Hiddemann, J. Bennett, T. Büchner, 1997, Annals of Hematology.

Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.

A. Ganser, B. Wörmann, O. Ottmann, 1994, Leukemia.

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

H. Heimpel, A. Ganser, K. Kliche, 2004, Leukemia.

Evolving treatment options of myelodysplastic syndromes

A. Ganser, W. Verbeek, 2001, Annals of Hematology.

Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/mitoxantrone chemotherapy with or without granulocyte/macrophage-colony-stimulating factor in high-risk myelodysplastic syndromes

W. Hiddemann, J. Bennett, C. Fonatsch, 1999, Journal of Cancer Research and Clinical Oncology.

The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML

A. Ganser, W. Hofmann, H. Koeffler, 2003, Leukemia.

JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms.

T. Brümmendorf, S. Koschmieder, A. Heine, 2015, Cancer research.

Mobilization of CD34‐positive tumour cells in a patient with testicular mixed germ cell tumour

W. Hiddemann, A. Humpe, W. Verbeek, 1995, British journal of haematology.

Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy.

A. Ganser, H. Serve, C. Müller-Tidow, 2004, Leukemia research.

Intensive therapy for high-risk myelodysplastic syndromes and the biological significance of karyotype abnormalities.

W. Hiddemann, C. Schoch, B. Wörmann, 1998, Leukemia research.

c-myb transactivates the human cyclin A1 promoter and induces cyclin A1 gene expression.

H. Koeffler, S. Diederichs, G. Idos, 1999, Blood.

Rectal adenocarcinoma with choriocarcinomatous differentiation: clinical and genetic aspects.

K. Donhuijsen, W. Dinjens, L. Looijenga, 2004, Human pathology.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

T. Brümmendorf, K. Spiekermann, M. Pfreundschuh, 2017, Leukemia.

Leukemia Remission Predicts the Relapse Risk in Acute Myeloid DNA Methylation of Tumor Suppressor Genes in Clinical

S. Koschmieder, W. Berdel, H. Serve, 2007 .

Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations.

W. Hiddemann, C. Fonatsch, B. Wörmann, 1995, Blood.

Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization.

S. Knuutila, M. Larramendy, K. Heinonen, 1993, Cancer genetics and cytogenetics.

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

J. Hasford, T. Brümmendorf, D. Hossfeld, 2016, Leukemia.

Cloning of the cyclin A1 Genomic Structure and Characterization of the Promoter Region

H. Koeffler, G. Idos, C. Müller, 1999, The Journal of Biological Chemistry.

PHAGOCYTES Myeloid Transcription Factor C / EBP e Is Involved in the Positive Regulation of Lactoferrin Gene Expression in Neutrophils

H. Koeffler, Dorothy J. Park, P. T. Vuong, 1999 .

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

J. Hasford, T. Brümmendorf, K. Spiekermann, 2018, Haematologica.

CD34+ subpopulations the level of early hematopoietic stem cells by cytogenetic analysis of Evidence for malignant transformation in acute myeloid leukemia at

C. Fonatsch, A. Pekrun, W. Verbeek, 2011 .

Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.

N. Kamada, E. Williamson, H. Koeffler, 1999, International journal of oncology.

The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes

W. Hiddemann, B. Wörmann, W. Verbeek, 2005, Journal of Cancer Research and Clinical Oncology.

Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia

A. Ganser, H. Serve, C. Müller-Tidow, 2003, British journal of haematology.

Chromosome Abnormalities and Karyotype Evolution in the Stem Cell Compartments of AML and MDS

W. Hiddemann, C. Fonatsch, B. Wörmann, 1997 .

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis

K. Döhner, R. Schlenk, H. Döhner, 2017, Leukemia.

Pomalidomide in Myelofibrosis with Cytopenia: First Results of the Mpnsg 01–09 Study (ClinicalTrials.gov Identifier: NCT00949364).

K. Döhner, R. Schlenk, M. Griesshammer, 2012 .

C/EBPε −/− mice: increased rate of myeloid proliferation and apoptosis

H. Koeffler, W. Verbeek, J Lekstrom-Himes, 2001, Leukemia.

The JAK Inhibitor Ruxolitinib Substantially Affects NK Cells in MPN Patients

T. Brümmendorf, S. Koschmieder, A. Heine, 2014 .

Induction of a hematological and cytogenetic remission in a patient with a myelodysplastic syndrome secondary to Fanconi's anemia employing the S-HAM regimen

W. Hiddemann, C. Schoch, B. Wörmann, 1997, Annals of Hematology.

In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF)

A. Ganser, B. Wörmann, W. Verbeek, 2002, Annals of Hematology.

DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.

S. Koschmieder, W. Berdel, H. Serve, 2007, Cancer research.

DNase I hypersensitivity analysis of the human CCAAT enhancer binding protein ε (C/EBPε) gene

A. Chumakov, H. Koeffler, H. Taguchi, 2001 .